Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1990;68(Suppl):172–177.

A liver-stage specific antigen of P. berghei identified by a monoclonal antibody.

L Winger 1, A Suhrbier 1, C A O'Dowd 1, K J Hodivala 1, R E Sinden 1
PMCID: PMC2393036  PMID: 2094583

Abstract

Stage-specific immunity (to the sporozoite, the asexual blood-stages and the sexual stages of malaria) has been well documented and antigens from each stage are being tested for their potential as vaccine candidates. Recently it has become clear that the liver stage can also be the target of protective immune responses; however, only the circumsporozoite protein has been identified as a protective liver antigen. It is critical for vaccine evaluation and development to identify other liver antigens and assess their potential role in immunity. In this paper we describe a monoclonal antibody, which recognizes a liver-specific antigen of Plasmodium berghei (referred to as Pbl1). Passive immunization studies using this antibody suggest that it may influence the course of sporozoite-induced infections.

Full text

PDF
172

Images in this article

174Fig. 1-4
on p.174

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Good M. F., Berzofsky J. A., Miller L. H. The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development. Annu Rev Immunol. 1988;6:663–688. doi: 10.1146/annurev.iy.06.040188.003311. [DOI] [PubMed] [Google Scholar]
  2. Guerin-Marchand C., Druilhe P., Galey B., Londono A., Patarapotikul J., Beaudoin R. L., Dubeaux C., Tartar A., Mercereau-Puijalon O., Langsley G. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature. 1987 Sep 10;329(6135):164–167. doi: 10.1038/329164a0. [DOI] [PubMed] [Google Scholar]
  3. Holder A. A. The precursor to major merozoite surface antigens: structure and role in immunity. Prog Allergy. 1988;41:72–97. [PubMed] [Google Scholar]
  4. Kumar S., Miller L. H., Quakyi I. A., Keister D. B., Houghten R. A., Maloy W. L., Moss B., Berzofsky J. A., Good M. F. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature. 1988 Jul 21;334(6179):258–260. doi: 10.1038/334258a0. [DOI] [PubMed] [Google Scholar]
  5. Mazier D., Miltgen F., Nudelman S., Nussler A., Renia L., Pied S., Goma J., Gentilini M. Pre-erythrocytic stages of plasmodia. Role of specific and nonspecific factors. Biol Cell. 1988;64(2):165–172. doi: 10.1016/0248-4900(88)90076-7. [DOI] [PubMed] [Google Scholar]
  6. Patarroyo M. E., Amador R., Clavijo P., Moreno A., Guzman F., Romero P., Tascon R., Franco A., Murillo L. A., Ponton G. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 1988 Mar 10;332(6160):158–161. doi: 10.1038/332158a0. [DOI] [PubMed] [Google Scholar]
  7. Sadoff J. C., Ballou W. R., Baron L. S., Majarian W. R., Brey R. N., Hockmeyer W. T., Young J. F., Cryz S. J., Ou J., Lowell G. H. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science. 1988 Apr 15;240(4850):336–338. doi: 10.1126/science.3281260. [DOI] [PubMed] [Google Scholar]
  8. Schofield L., Villaquiran J., Ferreira A., Schellekens H., Nussenzweig R., Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 1987 Dec 17;330(6149):664–666. doi: 10.1038/330664a0. [DOI] [PubMed] [Google Scholar]
  9. Szarfman A., Walliker D., McBride J. S., Lyon J. A., Quakyi I. A., Carter R. Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages. J Exp Med. 1988 Jan 1;167(1):231–236. doi: 10.1084/jem.167.1.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Terzakis J. A., Vanderberg J. P., Foley D., Shustak S. Exoerythrocytic merozoites of Plasmodium berghei in rat hepatic Kupffer cells. J Protozool. 1979 Aug;26(3):385–389. doi: 10.1111/j.1550-7408.1979.tb04641.x. [DOI] [PubMed] [Google Scholar]
  11. Weiss W. R., Sedegah M., Beaudoin R. L., Miller L. H., Good M. F. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci U S A. 1988 Jan;85(2):573–576. doi: 10.1073/pnas.85.2.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Winger L. A., Tirawanchai N., Nicholas J., Carter H. E., Smith J. E., Sinden R. E. Ookinete antigens of Plasmodium berghei. Appearance on the zygote surface of an Mr 21 kD determinant identified by transmission-blocking monoclonal antibodies. Parasite Immunol. 1988 Mar;10(2):193–207. doi: 10.1111/j.1365-3024.1988.tb00214.x. [DOI] [PubMed] [Google Scholar]
  13. Zavala F., Hollingdale M. R., Schwartz A. L., Nussenzweig R. S., Nussenzweig V. Immunoradiometric assay to measure the in vitro penetration of sporozoites of malaria parasites into hepatoma cells. J Immunol. 1985 Feb;134(2):1202–1205. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES